Autologous Adipose Cells Therapy
CERM INC. · NCT06869252
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–80 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 1, Phase 2
- Target enrollment
- 40
- US sites recruiting
- 2
- Study start
- August 1, 2025
- Record last updated
- May 31, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.
Being studied: Autologous Adipose Cells Therapy
Conditions: Hair Loss/Baldness; Wrinkle Appearance; Volume; Fine Lines; Skin Elasticity; Hair Thinning; Skin Pigmentation; Skin Texture
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.
- Outpatients who are experiencing hair loss or hair thinning
- Provision of signed and dated informed consent form
- Clearly stated willingness to comply with all the procedures of the study and availability of the study
- Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor
Exclusion Criteria
- Pregnancy or lactation
- Known allergic reaction to components of cell culture media
- Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
- Chronic infections, e.g. skin fungi infection, psoriasis
- Chronic wound healing
- Currently taking hormone therapy
- History of cancers and active cancers
- Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.
Recruiting US locations
The Centre for Cosmetic Surgery & Medicine, Newark
Lewes, DE 19958
Site contact: Dr. Abdollah M. Malekzadeh, MD · 302-645-7672 · lewes@thecentreforcosmeticsurgery.com
The Centre for Cosmetic Surgery & Medicine
Newark, DE 19713
Site contact: Dr. Abdollah M. Malekzadeh, MD · 302-994-8492 · lewes@thecentreforcosmeticsurgery.com
Study contacts (from the official record)
- Ankeet Dixit · 813-992-2521 · ankeetdixit@cermbio.com
- Wing Nam Fung · 207-671-9370 · wingnam@cermbio.com